• home
• sitemap
• contact

• Products
  • Instruments
    • MAGPIX
    • Luminex 100/200
    • FLEXMAP 3D
    • Dried Bio-Sample Automation
  • Assays
    • Clinical Diagnostics
      • xTAG Cystic Fibrosis
      • xTAG RVP
      • xTAG GPP
      • xTAG CYP2D6
      • MultiCode-RTx HSV 1&2
      • Analyte Specific Reagents
      • Clinical Assays in Development
    • Life Science Research
      • FlexScript LDA
      • SelecTAG
      • Protein
    • Assay Development Tools
    • xMAP Menu
  • Reagents/Microspheres
  • Software
  • Replacement Parts
• Technologies & Science
  • xMAP Technology
  • xTAG Technology
  • MultiCode Technology
  • Learning Center & References
• Applications
  • Clinical Diagnostics
    • Allergy Testing
    • Autoimmune Disease
    • Cystic Fibrosis
    • HLA Testing
    • Infectious Disease
    • Pharmacogenomics
    • Respiratory Viral Testing
  • Life Science Research
    • Alzheimer's
    • Biodefense/Environmental
    • Cancer Markers
    • Cardiac Markers
    • Cellular Signaling
    • Cytokines, Chemokines, & Growth Factors
    • Gene Expression Profiling
    • Genotyping
    • Endocrinology
    • Isotyping
    • Matrix Metalloproteinases
    • Metabolic Markers
    • Neurobiology
    • Transcription Factors/Nuclear Receptors
    • Vaccine Testing
  • Assay Development Tools
  • xMAP Menu
• Partners
  • Clinical Diagnostics
  • Life Science Research
  • Certified Developer Program
    • Certified Developers
    • Become a Certified Developer
  • Become a Partner
  • Become a Distributor
• Support
  • Technical Support Overview
    • Support Login
    • Support Registration
  • Training
  • Field Service
    • Certified Service Providers
    • Maintenance and Support
    • Luminex Central Repair Facility
    • Service Provider Login - Field Service Parts
  • Support Resources
• Downloads
• About Us
  • Message from CEO
  • Management
  • Events
  • Careers
  • News
  • Investor Relations
  • Contact Luminex
• Blog

High Throughput Genomics (HTG)

Company Description
High Throughput Genomics (HTG) was founded in 1997 with the mission to develop a universal molecular biology-based platform to improve the pharmaceutical drug discovery process. Since that time, HTG has expanded the utility of qNPA™ technology into the fields of gene expression (miRNA and mRNA) profiling, Translational Medicine and Diagnostic applications.

Products and Services
Our quantitative Nuclease Protection Assay (qNPA™) Technology is designed to deliver robust and reliable results with a simple, automatable protocols. qNPA technology is ideal for detecting small yet important changes in gene expression levels which other gene expression platforms cannot reliably detect. The unique combination of precision, linearity and accuracy with the fast, no RNA extraction protocol provides researchers and clinical investigators with a tool ideal for gene expression analysis in moderate to high sample volume research settings using a wide array of sample types including FFPE.

Contact Information
3430 E Global Loop
Tucson, AZ 85706
USA
Phone: (520) 547-2827
Fax: (520) 547-2328
www.htgenomics.com